We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
-4.8%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$698M
AUM Growth
+$539M
(+340%)
Cap. Flow
+$604M
Cap. Flow
% of AUM
86.56%
Top 10 Holdings %
Top 10 Hldgs %
44.92%
Holding
64
New
30
Increased
17
Reduced
2
Closed
14
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$64.2M |
| 2 |
Merck
MRK
|
+$40.5M |
| 3 |
McKesson
MCK
|
+$35.6M |
| 4 |
AbbVie
ABBV
|
+$32.6M |
| 5 |
Cardinal Health
CAH
|
+$26.2M |
Top Sells
| 1 |
Baxter International
BAX
|
+$13.8M |
| 2 |
HCA Healthcare
HCA
|
+$9.27M |
| 3 |
Zimmer Biomet
ZBH
|
+$8.16M |
| 4 |
Edwards Lifesciences
EW
|
+$6.3M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$5.76M |
Sector Composition
| 1 | Healthcare | 95.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $66.9M | 9.59% |
+580,000
| New | +$64.2M |
|
|
2
Merck
MRK
$305B
| $37.9M | 5.43% |
+515,616
| New | +$40.5M |
|
|
3
AbbVie
ABBV
$431B
| $36.3M | 5.21% |
477,000
+383,000
| +407% | +$32.6M |
|
|
4
McKesson
MCK
$93.2B
| $32.9M | 4.71% |
+243,000
| New | +$35.6M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.4B
| $25.5M | 3.66% |
+302,000
| New | +$26M |
|
6
Regeneron Pharmaceuticals
REGN
$69.7B
| $24.4M | 3.5% |
+50,000
| New | +$20.6M |
|
|
7
Cardinal Health
CAH
$52.7B
| $24.2M | 3.47% |
+505,000
| New | +$26.2M |
|
|
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $22.7M | 3.25% |
295,000
+231,000
| +361% | +$20.7M |
|
|
CTLT
9
DELISTED
CATALENT, INC.
CTLT
| $21.4M | 3.06% |
411,000
+319,000
| +347% | +$17.4M |
|
|
MNTA
10
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $21.2M | 3.04% |
780,000
+580,000
| +290% | +$16.1M |
|
11
Biogen
BIIB
$29.1B
| $19.6M | 2.81% |
+62,000
| New | +$18.8M |
|
12
Exelixis
EXEL
$14B
| $18.7M | 2.68% |
+1,086,000
| New | +$19.9M |
|
|
BHVN
13
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.4M | 2.63% |
+540,000
| New | +$24.7M |
|
14
Alector
ALEC
$167M
| $17.2M | 2.47% |
+714,000
| New | +$18.2M |
|
15
Aurinia Pharmaceuticals
AUPH
$2.07B
| $17.2M | 2.46% |
1,182,000
+950,000
| +409% | +$16.8M |
|
16
CVS Health
CVS
$135B
| $16.4M | 2.36% |
+277,000
| New | +$18.5M |
|
17
Acadia Pharmaceuticals
ACAD
$4.44B
| $15.1M | 2.16% |
357,000
+303,000
| +561% | +$12.5M |
|
18
Gilead Sciences
GILD
$164B
| $15M | 2.14% |
+200,000
| New | +$13.8M |
|
|
XLRN
19
DELISTED
Acceleron Pharma
XLRN
| $14.9M | 2.14% |
+166,000
| New | +$12.9M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals
ALXN
| $14.4M | 2.06% |
+160,000
| New | +$15.7M |
|
|
SGEN
21
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $13.6M | 1.95% |
+117,700
| New | +$13M |
|
|
DVAX
22
DELISTED
Dynavax Technologies
DVAX
| $13.5M | 1.94% |
3,824,000
+3,044,000
| +390% | +$14.1M |
|
|
KDMN
23
DELISTED
Kadmon Holdings, Inc.
KDMN
| $11.8M | 1.7% |
2,828,000
+1,998,000
| +241% | +$8.6M |
|
24
Axsome Therapeutics
AXSM
$12.2B
| $11.6M | 1.66% |
+197,000
| New | +$16.1M |
|
25
Cigna
CI
$78.8B
| $11.5M | 1.65% |
65,000
+35,000
| +117% | +$6.79M |
|
Similar funds
NM
LM
IF
PWAM
CM
LJAC
PO
SH